$2.41
Today
as of Sep 4, 16:48 ET
Last 30 days
Recent Press Releases & News
Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference
Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
Elicio Therapeutics: Q2 Earnings Snapshot
Overview
52-week range
$2.36
$16
0% of range
Avg surprise (last 3)
-19.4%
Avg reaction (last 2)
+10.3%
100% positive
Latest IV / EM
74%
EM ±12.0% · $3 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.43 | — | — | — | — | financials |
| Mon May 11, 2026 | Mar/2026 | $-0.65 | $-0.49 | -32.6% | +25.3% | +17.2% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.60 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.66 | $-0.69 | +4.3% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.87 | $-0.67 | -29.9% | — | +3.4% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-1.39 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.64 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.15 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.27 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-2.61 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-24.77 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-10M | $-11M | — | $-8M | $-10M | $-11M | — | $-10M |
| Net income | $-8M | $-12M | — | $-10M | $-11M | $-11M | — | $-19M |
| EPS (diluted) | $-0.43 | $-0.65 | — | $-0.60 | $-0.66 | $-0.87 | — | $-1.39 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $23M | $15M | $19M | $21M | $22M | $18M | $18M | $26M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $25M | $16M | $19M | $21M | $23M | $21M | $21M | $31M |
| Total assets | $31M | $23M | $26M | $28M | $30M | $28M | $28M | $38M |
| Long-term debt | $10M | $9M | $9M | $10M | $9M | — | $20M | — |
| Total liabilities | $23M | $24M | $24M | $24M | $28M | $19M | $39M | $57M |
| Total equity | $8M | $-1M | $2M | $4M | $2M | $9M | $-11M | $-19M |